X
Record #47343

Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy

Publisher
Frontiers
Original paper date
Jul 12, 2021
Institution
Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran · Department of Pharmaceutics, College of Pharmacy, Almaaqal University, Basra, Iraq · College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq · Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaymaniyah, Iraq · Department of Biophysics, College of Applied Sciences, University of Anbar, Ramadi, Iraq · Sechenov First Moscow State Medical University, Moscow, Russia · Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia · Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt · Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran · Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Gonabad University of Medical Sciences, Gonabad, Iran · Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States · Faculty Affairs, Taneja College of Pharmacy, University of South Florida, Tampa, FL, United States · Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia · DigiCare Behavioral Research, Casa Grande, AZ, United States · German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Open access
No
Article type
Review Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(HSC) Medicine - Drug Design(HSC) Medicine - Oncology
Notes from Retraction Watch

see also: https://blog.frontiersin.org/2023/09/04/frontiers-implements-new-policy-to-counter-authorship-for-sale/

Citation lifecycle

How this paper is being cited

Pre-retraction
17
Same day
0
Post-retraction
4
% post-retraction
19.0%
~7.9 citations/yr before retraction · ~1.3 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse